|
Sun Pharmaceutical Industries Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
431040.53 Cr.
|
P/BV
|
5.31
|
Book Value (Rs.)
|
338.51
|
|
52 Week High/Low (Rs.)
|
1917/1548
|
FV/ML
|
1/1
|
P/E(X)
|
37.55
|
|
Bookclosure
|
05/02/2026
|
EPS (Rs.)
|
47.84
|
Div Yield (%)
|
0.89
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 47.80 | 45.60 | 39.90 | 35.30 | 13.60 |
| Diluted EPS (Rs.) | 47.80 | 45.60 | 39.90 | 35.30 | 13.60 |
| Cash EPS (Rs.) | 60.44 | 56.50 | 50.87 | 46.22 | 23.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 348.31 | 301.00 | 265.36 | 247.22 | 212.84 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 348.31 | 301.00 | 265.36 | 247.22 | 212.84 |
| Revenue From Operations / Share (Rs.) | 243.66 | 219.14 | 202.13 | 182.91 | 161.11 |
| PBDIT / Share (Rs.) | 82.12 | 71.84 | 59.92 | 51.19 | 47.18 |
| PBIT / Share (Rs.) | 69.88 | 61.11 | 49.27 | 40.64 | 38.24 |
| PBT / Share (Rs.) | 64.62 | 57.32 | 46.21 | 39.21 | 18.68 |
| Net Profit / Share (Rs.) | 48.20 | 45.76 | 40.21 | 35.68 | 14.20 |
| NP After MI And SOA / Share (Rs.) | 47.84 | 45.55 | 39.91 | 35.32 | 13.64 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 33.70 | 32.78 | 29.64 | 27.98 | 29.28 |
| PBIT Margin (%) | 28.67 | 27.88 | 24.37 | 22.22 | 23.73 |
| PBT Margin (%) | 26.52 | 26.15 | 22.86 | 21.43 | 11.59 |
| Net Profit Margin (%) | 19.78 | 20.88 | 19.89 | 19.50 | 8.81 |
| NP After MI And SOA Margin (%) | 19.63 | 20.78 | 19.74 | 19.30 | 8.46 |
| Return on Networth / Equity (%) | 13.73 | 15.13 | 15.04 | 15.13 | 6.81 |
| Return on Capital Employeed (%) | 19.45 | 19.83 | 17.26 | 16.02 | 17.44 |
| Return On Assets (%) | 10.55 | 11.86 | 11.20 | 10.49 | 4.68 |
| Total Debt / Equity (X) | 0.04 | 0.02 | 0.04 | 0.11 | 0.01 |
| Asset Turnover Ratio (%) | 0.58 | 0.59 | 0.58 | 0.58 | 0.56 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.82 | 2.89 | 2.56 | 2.00 | 2.04 |
| Quick Ratio (X) | 2.32 | 2.33 | 1.98 | 1.48 | 1.51 |
| Inventory Turnover Ratio (X) | 5.38 | 5.23 | 4.76 | 0.79 | 0.78 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 33.06 | 30.26 | 29.73 | 65.96 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 26.76 | 23.88 | 22.89 | 39.85 |
| Earning Retention Ratio (%) | 0.00 | 66.94 | 69.74 | 70.27 | 34.04 |
| Cash Earning Retention Ratio (%) | 0.00 | 73.24 | 76.12 | 77.11 | 60.15 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 58.14 | 74.50 | 60.29 | 71.40 | 88.88 |
| Interest Coverage Ratio (Post Tax) (%) | 37.84 | 51.39 | 43.53 | 51.77 | 63.60 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 414429.17 | 407192.46 | 384570.80 | 239622.86 | 218440.19 |
| EV / Net Operating Revenue (X) | 7.09 | 7.74 | 7.93 | 5.46 | 5.65 |
| EV / EBITDA (X) | 21.03 | 23.62 | 26.75 | 19.51 | 19.30 |
| MarketCap / Net Operating Revenue (X) | 7.21 | 7.92 | 8.02 | 5.37 | 5.68 |
| Retention Ratios (%) | 0.00 | 66.93 | 69.73 | 70.26 | 34.03 |
| Price / BV (X) | 5.05 | 5.77 | 6.11 | 4.21 | 4.57 |
| Price / Net Operating Revenue (X) | 7.21 | 7.92 | 8.02 | 5.37 | 5.68 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 |
